|
|
Blood, 1 February 2007, Vol. 109, No. 3, pp. 1131-1137.
Prepublished online as a Blood First Edition Paper on September 19, 2006; DOI 10.1182/blood-2006-05-023770.
 Previous Article | Next Article 
Submitted May 17, 2006
Accepted September 5, 2006
Control of coronavirus infection through plasmacytoid dendritic cell-derived type I interferon
Luisa Cervantes-Barragan, Roland Zust, Friedemann Weber, Martin Spiegel, Karl S. Lang, Shizuo Akira, Volker Thiel, and Burkhard Ludewig*
Research Dept, Kantonal Hospital St. Gallen, Switzerland
Institut fur Medizinische Mikrobiologie und Hygiene, University of Freiburg, Germany
Institute of Experimental Immunology, University Hospital Zurich, Switzerland
Dept of Host Defense, Osaka University, Japan.
* Corresponding author; email: burkhard.ludewig{at}kssg.ch.
This study demonstrates a unique and crucial role of plasmacytoid dendritic cells (pDCs) and pDC-derived type I interferons (IFNs) in the pathogenesis of mouse coronavirus infection. pDCs controlled the fast replicating mouse hepatitis virus (MHV) through the immediate production of type I IFNs. Recognition of MHV by pDCs was mediated via TLR7 ensuring a swift IFN- production following encounter with this cytopathic RNA virus. Furthermore, the particular type I IFN response pattern was not restricted to the murine coronavirus, but also found in infection with the highly cytopathic human severe acute respiratory syndrome (SARS) coronavirus. Taken together, our results suggest that rapid production of type I IFNs by pDCs is essential for the control of potentially lethal coronavirus infections.
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati What's this?
This article has been cited by other articles:
|
|
|
|
 
T. Kuri, X. Zhang, M. Habjan, L. Martinez-Sobrido, A. Garcia-Sastre, Z. Yuan, and F. Weber
Interferon priming enables cells to partially overturn the SARS coronavirus-induced block in innate immune activation
J. Gen. Virol.,
November 1, 2009;
90(11):
2686 - 2694.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. Khanolkar, S. M. Hartwig, B. A. Haag, D. K. Meyerholz, L. L. Epping, J. S. Haring, S. M. Varga, and J. T. Harty
Protective and Pathologic Roles of the Immune Response to Mouse Hepatitis Virus Type 1: Implications for Severe Acute Respiratory Syndrome
J. Virol.,
September 15, 2009;
83(18):
9258 - 9272.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. K. Roth-Cross, H. Stokes, G. Chang, M. M. Chua, V. Thiel, S. R. Weiss, A. E. Gorbalenya, and S. G. Siddell
Organ-Specific Attenuation of Murine Hepatitis Virus Strain A59 by Replacement of Catalytic Residues in the Putative Viral Cyclic Phosphodiesterase ns2
J. Virol.,
April 15, 2009;
83(8):
3743 - 3753.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
P. A. Lang, L. Cervantes-Barragan, A. Verschoor, A. A. Navarini, M. Recher, M. Pellegrini, L. Flatz, A. Bergthaler, K. Honda, B. Ludewig, et al.
Hematopoietic cell-derived interferon controls viral replication and virus-induced disease
Blood,
January 29, 2009;
113(5):
1045 - 1052.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
L. Cervantes-Barragan, U. Kalinke, R. Zust, M. Konig, B. Reizis, C. Lopez-Macias, V. Thiel, and B. Ludewig
Type I IFN-Mediated Protection of Macrophages and Dendritic Cells Secures Control of Murine Coronavirus Infection
J. Immunol.,
January 15, 2009;
182(2):
1099 - 1106.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
K. K. Eriksson, L. Cervantes-Barragan, B. Ludewig, and V. Thiel
Mouse Hepatitis Virus Liver Pathology Is Dependent on ADP-Ribose-1''-Phosphatase, a Viral Function Conserved in the Alpha-Like Supergroup
J. Virol.,
December 15, 2008;
82(24):
12325 - 12334.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. Frieman and R. Baric
Mechanisms of Severe Acute Respiratory Syndrome Pathogenesis and Innate Immunomodulation
Microbiol. Mol. Biol. Rev.,
December 1, 2008;
72(4):
672 - 685.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. K. Roth-Cross, S. J. Bender, and S. R. Weiss
Murine Coronavirus Mouse Hepatitis Virus Is Recognized by MDA5 and Induces Type I Interferon in Brain Macrophages/Microglia
J. Virol.,
October 15, 2008;
82(20):
9829 - 9838.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
T. Baas, A. Roberts, T. H. Teal, L. Vogel, J. Chen, T. M. Tumpey, M. G. Katze, and K. Subbarao
Genomic Analysis Reveals Age-Dependent Innate Immune Responses to Severe Acute Respiratory Syndrome Coronavirus
J. Virol.,
October 1, 2008;
82(19):
9465 - 9476.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
K. Narayanan, C. Huang, K. Lokugamage, W. Kamitani, T. Ikegami, C.-T. K. Tseng, and S. Makino
Severe Acute Respiratory Syndrome Coronavirus nsp1 Suppresses Host Gene Expression, Including That of Type I Interferon, in Infected Cells
J. Virol.,
May 1, 2008;
82(9):
4471 - 4479.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
G. Tekes, R. Hofmann-Lehmann, I. Stallkamp, V. Thiel, and H.-J. Thiel
Genome Organization and Reverse Genetic Analysis of a Type I Feline Coronavirus
J. Virol.,
February 15, 2008;
82(4):
1851 - 1859.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
N. Ank, M. B. Iversen, C. Bartholdy, P. Staeheli, R. Hartmann, U. B. Jensen, F. Dagnaes-Hansen, A. R. Thomsen, Z. Chen, H. Haugen, et al.
An Important Role for Type III Interferon (IFN-{lambda}/IL-28) in TLR-Induced Antiviral Activity
J. Immunol.,
February 15, 2008;
180(4):
2474 - 2485.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
D. D. C. Ireland, S. A. Stohlman, D. R. Hinton, R. Atkinson, and C. C. Bergmann
Type I Interferons Are Essential in Controlling Neurotropic Coronavirus Infection Irrespective of Functional CD8 T Cells
J. Virol.,
January 1, 2008;
82(1):
300 - 310.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. J. Robertson, C. G. Ammann, R. J. Messer, A. B. Carmody, L. Myers, U. Dittmer, S. Nair, N. Gerlach, L. H. Evans, W. A. Cafruny, et al.
Suppression of Acute Anti-Friend Virus CD8+ T-Cell Responses by Coinfection with Lactate Dehydrogenase-Elevating Virus
J. Virol.,
January 1, 2008;
82(1):
408 - 418.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
N. Zucchini, G. Bessou, S. H. Robbins, L. Chasson, A. Raper, P. R. Crocker, and M. Dalod
Individual plasmacytoid dendritic cells are major contributors to the production of multiple innate cytokines in an organ-specific manner during viral infection
Int. Immunol.,
January 1, 2008;
20(1):
45 - 56.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. G. Devaraj, N. Wang, Z. Chen, Z. Chen, M. Tseng, N. Barretto, R. Lin, C. J. Peters, C.-T. K. Tseng, S. C. Baker, et al.
Regulation of IRF-3-dependent Innate Immunity by the Papain-like Protease Domain of the Severe Acute Respiratory Syndrome Coronavirus
J. Biol. Chem.,
November 2, 2007;
282(44):
32208 - 32221.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. J. Cameron, L. Ran, L. Xu, A. Danesh, J. F. Bermejo-Martin, C. M. Cameron, M. P. Muller, W. L. Gold, S. E. Richardson, S. M. Poutanen, et al.
Interferon-Mediated Immunopathological Events Are Associated with Atypical Innate and Adaptive Immune Responses in Patients with Severe Acute Respiratory Syndrome
J. Virol.,
August 15, 2007;
81(16):
8692 - 8706.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. K. Roth-Cross, L. Martinez-Sobrido, E. P. Scott, A. Garcia-Sastre, and S. R. Weiss
Inhibition of the Alpha/Beta Interferon Response by Mouse Hepatitis Virus at Multiple Levels
J. Virol.,
July 1, 2007;
81(13):
7189 - 7199.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
U. Schleicher, J. Liese, I. Knippertz, C. Kurzmann, A. Hesse, A. Heit, J. A.A. Fischer, S. Weiss, U. Kalinke, S. Kunz, et al.
NK cell activation in visceral leishmaniasis requires TLR9, myeloid DCs, and IL-12, but is independent of plasmacytoid DCs
J. Exp. Med.,
April 16, 2007;
204(4):
893 - 906.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
H. Zhou and S. Perlman
Mouse Hepatitis Virus Does Not Induce Beta Interferon Synthesis and Does Not Inhibit Its Induction by Double-Stranded RNA
J. Virol.,
January 15, 2007;
81(2):
568 - 574.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
